Adenine for guanine substitution — pairs 5‘ to the apolipoprotein (APO) A4 gene: relation with hgh density lipoprotein cholesterol and APO A‐I concentrations
- 1 December 1993
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 44 (6) , 307-312
- https://doi.org/10.1111/j.1399-0004.1993.tb03906.x
Abstract
A common mutation, adenine (A) for guanidine (G) substitution (G/A) has been located -78 bp 5' to the apo A-I gene. This region has been shown to be involved in the transcriptional regulation of the apo A-I gene. Previous studies have shown that this mutation is associated with altered high density lipoprotein cholesterol (HDL-C) levels, although these findings have not been consistent. We have studied the frequency of this mutation in 125 subjects (60 males and 65 females) selected because they had HDL-C levels below the 25th (low HDL) or above the 75th (high HDL) percentile of the population distribution. The presence of the mutation was detected by Msp I digestion of a 259 bp fragment of PCR amplified DNA. The allele frequency was similar in both groups (0.20 for the lowest HDL group and 0.28 for the highest HDL group, p > 0.05), although a non-significant trend was observed in a higher frequency of the A/A genotype in the highest HDL females (17.5%) vs only 6.7% in the lowest HDL female group. In conclusion, in this population the G/A mutation was not significantly associated with HDL-C or apo A-I plasma levels.Keywords
This publication has 28 references indexed in Scilit:
- Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro.Journal of Clinical Investigation, 1992
- The MspI restriction fragment length polymorphism 3′ to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery diseaseAtherosclerosis, 1992
- Reverse cholesterol transportCurrent Opinion in Lipidology, 1991
- Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AINature, 1991
- Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.Journal of Clinical Investigation, 1990
- Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding ProteinsScience, 1989
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- THE TROMSØHEART-STUDYThe Lancet, 1977